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during hospitalization, mortality, and disability measured on 
the modified Rankin Scale  ≥ 2–5, in which 2 indicates an in-
dependence/slight disability to 5 severe disability.  Results: 
Of 12,276 patients (mean age 73 ± 13; 49% women), 9,164 
patients (74%) underwent dysphagia screening; of these pa-
tients, 55, 39, 4.7, and 1.5% of patients had been screened for 
dysphagia within 3, 3 to <24, 24 to  ≤ 72, and >72 h following 
admission. Patients who underwent dysphagia screening 
were likely to be older, more affected on the National Insti-
tutes of Health Stroke Scale score, and to have higher rates 
of neurological symptoms and risk factors than patients who 
were not screened. A total of 3,083 patients (25.1%; 95% CI 
24.4–25.8) had dysphagia. The frequency of dysphagia was 
higher in patients who had undergone dysphagia screening 
than in those who had not (30 vs. 11.1%; p < 0.001). During 
hospitalization (mean 9 days), 1,271 patients (10.2%; 95% CI 
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 Abstract 
 Background: Dysphagia is associated with poor outcome in 
stroke patients. Studies investigating the association of dys-
phagia and early dysphagia screening (EDS) with outcomes 
in patients with acute ischemic stroke (AIS) are rare. The aims 
of our study are to investigate the association of dysphagia 
and EDS within 24 h with stroke-related pneumonia and out-
comes.  Methods: Over a 4.5-year period (starting November 
2007), all consecutive AIS patients from 15 hospitals in 
Schleswig-Holstein, Germany, were prospectively evaluat-
ed. The primary outcomes were stroke-related pneumonia 
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9.7–10.8) suffered from stroke-related pneumonia. Patients 
with dysphagia had a higher rate of pneumonia than those 
without dysphagia (29.7 vs. 3.7%; p < 0.001). Logistic regres-
sion revealed that dysphagia was associated with increased 
risk of stroke-related pneumonia (OR 3.4; 95% CI 2.8–4.2; p < 
0.001), case fatality during hospitalization (OR 2.8; 95% CI 
2.1–3.7; p < 0.001) and disability at discharge (OR 2.0; 95% CI 
1.6–2.3; p < 0.001). EDS within 24 h of admission appeared 
to be associated with decreased risk of stroke-related pneu-
monia (OR 0.68; 95% CI 0.52–0.89; p = 0.006) and disability at 
discharge (OR 0.60; 95% CI 0.46–0.77; p  < 0.001). Further-
more, dysphagia was independently correlated with an in-
crease in mortality (OR 3.2; 95% CI 2.4–4.2; p < 0.001) and 
disability (OR 2.3; 95% CI 1.8–3.0; p < 0.001) at 3 months after 
stroke. The rate of 3-month disability was lower in patients 
who had received EDS (52 vs. 40.7%; p = 0.003), albeit an as-
sociation in the logistic regression was not found (OR 0.78; 
95% CI 0.51–1.2; p = 0.2).  Conclusions: Dysphagia exposes 
stroke patients to a higher risk of pneumonia, disability, and 
death, whereas an EDS seems to be associated with reduced 
risk of stroke-related pneumonia and disability. 
 © 2016 S. Karger AG, Basel 
 Introduction 
 Dysphagia is a common neurological symptom of 
stroke and portends a higher risk of complication after 
stroke, particularly pneumonia caused by the dysfunc-
tion of cough reflex and aspiration and advanced by 
stroke-induced immunodepression  [1, 2] . Studies have 
shown that dysphagia affects up to two thirds of patients 
with stroke  [3–5] , depending on the stroke’s type, size, 
site and severity. Furthermore, the occurrence of dys-
phagia in patients with stroke has been linked to poor 
outcomes with higher risks for pneumonia, mortality 
and disability  [3, 5] . Stroke-related pneumonia has been 
found to be correlated with longer periods of hospitaliza-
tion and an increase in the financial costs of the medical 
care of stroke patients  [6] . Studies have found that early 
aspiration prophylaxis using tube feeding after stroke 
may reduce case fatality; however, early feeding of stroke 
patients with dysphagia by percutaneous endoscopic 
gastrostomy (PEG) was not supported  [7] . Stroke guide-
lines recommend that early dysphagia screening (EDS) 
be performed in stroke patients to detect swallowing dif-
ficulties and to prevent stroke-related pneumonia caused 
by aspiration combined with impairment of humeral and 
neural systems  [6, 8] . Although there is no doubt about 
the relevance of dysphagia in acute ischemic stroke (AIS), 
large-scale quantitative data on stroke-associated dys-
phagia and pneumonia in large cohort are lacking. With 
this prospectively designed hospital-based study, we 
aimed to study the association between dysphagia as well 
as EDS within 24 h of admission with the occurrence of 
stroke-related pneumonia and outcome.
 Methods 
 Study Design 
 From November 2007 through March 2012, a total of 12,781 
patients (mean age 73 ± 13; 48.6% women; median National Insti-
tutes of Health Stroke Scale (NIHSS) score, 4 (interquartile range 
(IQR) 2–9)) with AIS were included in this hospital-based study. 
The study is a part of the ongoing stroke registry, Quality of Treat-
ment of Stroke in the Federal State Schleswig-Holstein (in  German, 
Qualitätsgemeinschaft Schlaganfallversorgung in Schleswig-Hol-
stein (QugSS2)) as benchmarking project to improve stroke care 
in Schleswig-Holstein. The project (QugSS2), which has been pre-
viously described  [9] , includes all 15 hospitals involved in the treat-
ment of patients with stroke in the German federal state of 
Schleswig-Holstein, which has 2.8 million inhabitants. The stroke 
care among included hospitals is standardized as recommended by 
the German Stroke Society and German Association of Neurology. 
The inclusion criterion of the study were that the patients had to 
be residents of the state of Schleswig-Holstein with a diagnosis of 
AIS. The diagnosis of stroke was based on clinical presentation and 
brain imaging (cranial CT and MRI). Documentation and data-
collection procedures that we conducted followed a uniform study 
manual as part of a benchmarking project.
 Data Acquisition 
 Data acquisition was performed prospectively during hospital-
ization from patient records. Medical histories or prior records 
were also included in the documentation of the data. The study 
protocol was placed in the individual file of each patient. The treat-
ing physicians filled in the baseline characteristics at admission 
and completed the protocol at discharge. Patients with AIS (age 
 ≥ 18 years) whose main residence was in the German federal state 
of Schleswig–Holstein were included. Stroke patients who present-
ed to the emergency department but declined hospital admission 
were not included in the stroke registry. Patients were also exclud-
ed from the study if they were admitted with suspected AIS but 
were given a different diagnosis after undergoing diagnostic evalu-
ation during hospitalization. Baseline characterizations including 
gender, age, modified Rankin Scale (mRS) score, NIHSS score, 
medical history, treatments of stroke, secondary prevention strat-
egies, and etiology of the stroke in accordance with the Trial of Org 
10172 in Acute Stroke Treatment (TOAST) classification were re-
corded  [10] . The case fatality was defined as mortality during hos-
pitalization, whereas disability as mRS  ≥ 2–5 at discharge and after 
3 months.
 Follow-Up Evaluation 
 At discharge, stroke patients or caregivers were asked whether 
they agreed to be included in the follow-up questionnaire that was 























   
   
   
   
   
   
   


























by letter. Those patients who did not respond to the letter were 
then contacted by telephone. If they were not available, we evalu-
ated mortality at 3 months after discharge by sending an online 
request to the registration office of the German federal state of 
Schleswig-Holstein. If discharged patients were no longer residing 
in the state of Schleswig-Holstein, they were considered lost to 
follow-up.
 Dysphagia Screening 
 In accordance with the stroke unit care and as part of the stroke 
registry protocol, every stroke patient should undergo a dysphagia 
screening at admission as soon as possible regardless of the neuro-
logical symptoms and whether a dysphagia was suspected or not. 
Nurses or treating physicians performed systematic dysphagia 
screening clinically on admitted patients before feeding or adminis-
tration of oral drugs. Water and/or thickened apple juice were used 
to test whether swallowing abnormalities were evident. In addition, 
swallowing and cough provocation assessments were performed us-
ing a thin tube inserted into the oropharynx area to test the sensory 
input and motor output in the pharynx area. With this procedure, 
the delay or lack of the initiation of the swallowing process can be 
assessed in order to detect the silent aspiration. Dysphagia was deter-
mined in cases of deglutition, drooling, absent swallow reflex, cough 
or voice change after swallowing, reduced water control, decreased 
oral clearance, or involuntary cough. If swallowing difficulties were 
suspected, swallowing therapists repeated the dysphagia screening 
and possibly performed further dysphagia tests; in addition, mea-
sures of swallowing therapy were initiated. In cases with evidence of 
dysphagia after hospital admission, initial feeding and the adminis-
tration of drugs were carried out through peripheral or/and central 
venous catheter or by nasogastral tubes. When dysphagia was persis-
tent during the hospitalization, PEG was generally initiated before 
patients were discharged or during the rehabilitations period.
 Pneumonia 
 In accordance with the criteria used in the literature to diagnose 
pneumonia after stroke, although a wide range of definition exists 
 [6] , the diagnosis in this study was based on a combination of clin-
ical presentations, radiologic signs detected on a chest X-ray, and 
blood test results (C-reactive protein and leukocytes).
 Standard Protocol Approval, Registration, and Patient Consent 
 Approval for the study was obtained from the local Ethics 
Committee of the University of Lübeck. Entry in the stroke registry 
was obligatory as part of the benchmarking project to improve 
stroke care. At the time of discharge from the hospital, stroke pa-
tients or caregivers were asked if they could be included in the 
follow-up evaluation conducted 3 months after discharge from the 
hospital. If they agreed to participate in the follow-up evaluation, 
an informed consent form was obtained from them.
 Statistics 
 The SPSS program (version 22; IBM SPSS Statistics, Armonk, 
N.Y., USA) was used to analyze data. We described with mean and 
SD values for continuous variables, median and IQR values for 
scores, and absolute numbers and percentages for nominal and 
categorical variables. We performed a chi-square test to determine 
the correlation between categorical variables, a t test between con-
tinuous variables, and a Mann–Whitney test between scores. Lo-
gistic regression was carried out to estimate the OR. Variables with 
a p value <0.1 were entered into the logistic regression model. A p 
value <0.05 was considered significant. In cases of multiple com-
parisons, a Bonferroni correction was used to show whether the 
individual comparison was significant or not.
 Results 
 Dysphagia 
 During a 4.5-year study period (starting November 
2007), 12,781 patients with AIS were admitted to 15 hos-
pitals. Most patients (87%) were admitted within 6 h of 
symptom onset. The time point of dysphagia screening 
was documented for 74% of patients (n = 9,164); of these 
patients, 55, 39, 4.7, and 1.5% of patients had been 
screened for dysphagia within 3, 3 to <24, 24 to  ≤ 72, and 
>72 h following admission. The rates of altered con-
sciousness were 9.7, 11.5, 16.5 and 26.9% in patients with 
AIS who were screened for dysphagia within 3, 3 to <24, 
24 to  ≤ 72, and >72 h of admission.
 A comparison between patients who underwent dys-
phagia screening and those who were not screened is 
shown in  table 1 as well as a comparison between patients 
who underwent an EDS within 24 vs. those who screened 
later is shown in  table 1 .
 For 12,276 patients (96%), data on the presence of dys-
phagia were available. Of these patients, 3,083 patients 
(25.1%; 95% CI 24.4–25.8) had dysphagia.
 The dysphagia rates were 27.5, 31.7, 41.8, and 42.3% in 
patients who had undergone dysphagia screening within 
3, 3 to <24, 24 to  ≤ 72, and >72 h following hospital admis-
sion, respectively ( fig.  1 ). When pooling into 2 groups 
(<24 vs.  ≥ 24 h), dysphagia incidence was significantly in-
creased among patients who were screened after 24 h of 
admission compared to those who underwent an EDS 
within 24 h of admission (42 vs. 29%; p < 0.001). As shown 
in  table 2 , AIS patients with dysphagia were more likely 
to be older (76 vs. 72 years, respectively; p < 0.001) and to 
have a higher NIHSS score at admission (13 vs. 3, respec-
tively; p < 0.001) than those without dysphagia. They also 
had a higher probability of altered consciousness at ad-
mission and speech dysfunction than patients without 
dysphagia.
 Stroke-Related Pneumonia and Outcomes 
 A total of 1,271 AIS patients (10.2%; 95% CI 9.7–10.8) 
had stroke-related pneumonia. A comparison of patients 
with dysphagia and those without dysphagia revealed 
that patients with dysphagia had higher rates of pneumo-
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(14.9 vs. 1.2%, respectively; p < 0.001) and a longer hos-
pitalization in acute care (10.5 vs. 9 days; p  < 0.001). 
Pneumonia occurred more often in patients who had un-
dergone dysphagia screening than in those who had not, 
independent from the result of this screening (12.1 vs. 
4.7%, respectively; p < 0.001). Risk to contract pneumo-
nia also increased with late dysphagia screening. The fre-
quency of pneumonia in patients who had not under-
gone dysphagia screening was 4.7%, whereas the fre-
quency of pneumonia in patients who had undergone 
dysphagia screening within 3, 3 to <24, 24 to  ≤ 72, and 
>72 h was 10.5, 13.2, 17.0, and 29.9%, respectively ( fig. 2 ). 
A total of 586 patients (4.7%; 95% CI 4.3–5.1) died dur-
ing a mean hospitalization time of 9 days. At discharge 
from the acute hospital, a disability (mRS  ≥ 2–5) was 
present in 60.7% of all AIS patients who survived. This 
Table 1.  Comparison between patients who underwent a dysphagia screening vs. those who did not and between patients who had EDS 
done within 24 h vs. delayed dysphagia screening
Baseline characteristics Dysphagia screening p value  EDS within 24 h p value
no (n = 3,267) yes (n = 9,164)  no (n = 563) yes (n = 8,601)
Age, years, mean ± SD 71±13 73±12 <0.001 72.4 (13) 73.4 (12) 0.06
Median NIHSS score (IQR) 3 (1–3) 4 (2–10) <0.001 7 (3–15) 4 (2–9) <0.001
Sex, male 1,657 (52) 4,661 (51) 0.1 268 (48) 4,393 (51) 0.1
Altered consciousness 245 (9) 992 (11) <0.001 105 (19) 887 (10) <0.001
Speech-dysfunction 1,359 (44) 6,024 (68) <0.001 380 (71) 5,644 (67) 0.14
Unilateral weakness 1,904 (61) 6,815 (75) <0.001 440 (79) 6,375 (75) 0.04
Hypertension 2,562 (82) 7,645 (85) <0.001 446 (81) 7,199 (85) 0.008
Diabetes mellitus 737 (24) 2,377 (27) 0.001 144 (26) 2,233 (27) 0.7
Hypercholesterolemia 1,593 (52) 4,890 (56) 0.001 242 (45) 4,648 (56) <0.001
Previous stroke 837 (27) 2,648 (30) 0.003 151 (27) 2,497 (30) 0.2
Atrial fibrillation 794 (26) 2,972 (33) <0.001 190 (34) 2,782 (33) 0.6
AT before stroke 1,240 (40) 3,900 (44) <0.001 235 (43) 3,665 (44) 0.8



























<3 h 3 to <24 h 24 to 72 h >72 h
 Fig. 1. Dyspaghia frequency in relation to time point of dysphagia 
screening. X-axis indicates time point of dysphagia screening, Y-
axis indicates frequency of dysphagia. 
 Fig. 2. Pneumonia frequency in relation to assessment time of dys-
phagia screening. X-axis indicates time point of dysphagia screen-























   
   
   
   
   
   
   


























risk of disability was much higher in patients with dys-
phagia than in those without (89.4 vs. 51.9%, respective-
ly; p  < 0.001) as well as in patients who experienced 
stroke-related pneumonia during hospitalization (89.9 
vs. 33.3%; p < 0.001). As shown in  table 3 , logistic regres-
sion reveals that dysphagia was independently associated 
with an increased risk of pneumonia (3.4; 95% CI 2.8–
4.2; p < 0.001), and case fatality (OR 2.8; 95% CI 2.1–3.7; 
p < 0.001) during hospitalization as well as disability at 
discharge (OR 2.0; 95% CI 1.6–2.3; p < 0.001). The ad-
ministration of an EDS within 24 h of admission appears 
to be associated with decreased risk of pneumonia during 
hospitalization (OR 0.68; 95% CI 0.52–0.89; p = 0.006) 
and disability at discharge (OR 0.60; 95% CI 0.46–0.77; 
p < 0.001).
 At discharge, a total of 7,518 patients or their care-
givers agreed to be included in the follow-up evaluation. 
Data on mortality or disability at 3 months after dis-
charge were recorded for 7,195 patients (96%) who 
were  included in the follow-up questionnaire. Of 
these 7,195 patients, 498 patients (6.9%; 95% CI 6.3–7.5) 
died during the 3-month period after discharge. The 
Table 2.  Comparison between patients with and without dysphagia
Baseline characteristics, therapeutic 
procedures and outcomes
 Dysphagia p value
 no (n = 9,193) yes (n = 3,083)
Age, years, mean ± SD 72±13 76±12 <0.001
Median NIHSS score (IQR) 3 (2–5) 13 (7–18) <0.001
Sex, male 4,981 (54) 1,336 (44) <0.001
Altered consciousness 221 (2.4) 1,012 (33) <0.001
Aphasia 2,145 (23) 1,803 (59) <0.001
Dysarthria 3,066 (34) 2,660 (87) <0.001
Unilateral weakness 5,865 (64) 2,824 (92) <0.001
Hypertension 7,552 (83) 2,615 (86) <0.001
Diabetes mellitus 2,223 (25) 846 (28) <0.001
Hypercholesterolemia 5,022 (57) 1,455 (50) <0.001
Previous stroke 2,405 (27) 1,050 (35) <0.001
Atrial fibrillation 2,340 (26) 1,404 (47) <0.001
AT before stroke 3,655 (41) 1,448 (49) <0.001
Stroke etiology (TOAST)
Large-artery atherosclerosis 1,996 (22)a 641 (21)a <0.001
Cardioembolism 2,871 (32) 1,501 (50)
Small-artery occlusion 2,236 (25) 268 (9)
Other determined etiology 265 (3)a 86 (3)a
Undetermined etiology 1,751 (19)a 567 (19)a
Dysphagia screening within 24 h 6,151 (69) 2,640 (89) <0.001
Dysphagia screening time, h <0.001
<3 3,503 (39) 1,331 (45)
3 to <24 2,343 (26) 1,089 (37)
24 to ≤72 230 (3) 165 (6)
>72 75 (1) 55 (2)
Intravenous therapy with rt-PA 575 (6) 561 (18) <0.001
Oral anticoagulation 2,657 (29) 805 (27) 0.006
CEA/stenting 364 (4.5) 60 (2.2) 0.001
Antiplatelet treatment 7,240 (80) 2,286 (75) 0.001
Thrombosis prophylaxis 7,675 (84) 2,588 (85) 0.2
Stroke-related pneumonia 337 (3.7) 917 (29.7) <0.001
Casa fatality 106 (1.2) 457 (14.9) <0.001
Disability at discharge (mRS ≥2) 4,628 (52) 2,291 (89) <0.001
Length of hospitalization, mean ± SD 9.2±5 10.5±7 <0.001
 AT = Antiplatelet therapy; CEA = carotid thromboendarterectomy. Data are n (%) unless otherwise indicated. 
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mortality rate at 3 months after discharge was higher in 
patients with dysphagia than in those without dyspha-
gia (20.7 vs. 3.4%, respectively; p < 0.001 (OR 3.2; 95% 
CI 2.4–4.2)). There existed an association between ESD 
within 24 h and mortality at 3 months. The mortality 
rate at 3 months of patients who received ESD com-
pared to patients with delayed dysphagia screening 
was not significantly different (8.0 vs. 9.4%, respectively; 
p = 0.4). Overall, we found that patients with dysphagia 
had a higher likelihood of 3-month disability (mRS  ≥ 2–
5) than patients without dysphagia (74 vs. 25%, respec-
tively; p  < 0.001 (OR 2.3; 95% CI 1.8–3.0)). In addi-
tion,  we found that patients with dysphagia who had 
undergone EDS within 24 h had a lower rate of 3-month 
disability than those who had undergone EDS later 
(40.7 vs. 52%, respectively; p = 0.003). The logistic re-
gression ( table 4 ) did not show an association between 
ESD and 3-month disability (OR 0.78; 95% CI 0.51–1.2; 
p = 0.2).
 Discussion 
 In this study, the frequency of dysphagia in patients 
with AIS is comparable to that of other investigations 
with a similar design  [11, 12] , but lower than dysphagia 
Table 3.  Associated factors with pneumonia, case fatality and disability (mRS ≥2) at discharge in the logistic regressions
Associated factors Pneumonia Case fatality  Disability at discharge
OR (95% CI) p value (RC) OR (95% CI) p value (RC) O R (95% CI) p value (RC)
Dysphagia 3.4 (2.8–4.2) <0.001 (1.23) 2.8 (2.1–3.7) <0.001 (1.01) 2.0 (1.6–2.3) <0.001 (0.66)
EDS within 24 h 0.68 (0.52–0.89) 0.006 (–0.13) – – 0.60 (0.46–0.77) <0.001 (–0.51)
Age >65 1.6 (1.3–2.0) <0.001 (0.46) 3.2 (2.2–4.8) <0.001 (1.1) 1.4 (1.2–1.6) <0.001 (0.31)
Male sex – – 1.2 (1.0–1.5) 0.07 (0.19) 0.9 (0.77–0.95) 0.004 (–0.15)
NIHSS score 1.09 (1.07–1.10) <0.001 (0.08) 1.11 (1.09–1.13) <0.001 (0.12) 1.23 (1.09–1.40) <0.001 (0.2)
Altered consciousness 1.3 (1.1–1.6) 0.002 (0.31) 2.8 (2.3–3.6) <0.001 (1.04) 1.0 (0.7–1.3) 0.9 (–0.16)
Speech dysfunction 1.6 (1.2–2.0) 0.001 (0.43) 1.7 (1.12–2.67) 0.01 (0.55) 1.5 (1.3–1.6) <0.001 (0.37)
Hypertension 1.1 (0.9–1.4) 0.3 (0.12) 1.0 (0.7–1.2) 0.5 (–0.1) 1.3 (1.1–1.5) 0.001 (0.25)
Diabetes mellitus 1.3 (1.1–1.6) 0.001 (0.28) – – 1.2 (1.1–1.4) 0.001 (0.2)
Previous stroke 1.0 (0.8–1.2) 0.8 (–0.02) 0.9 (0.7–1.1) 0.4 (–0.09) 1.6 (1.4–1.8) <0.001 (0.47)
Atrial fibrillation 1.6 (1.4–1.9) <0.001 (0.46) 1.4 (1.3–1.9) 0.006 (0.3) 1.2 (1.1–1.4) <0.001 (0.17)
 RC = Regression coefficient.
Table 4.  Associated factors with the mortality and the disability (mRS ≥2–5) at 3 months after discharge
Associated factors 3-month mortality  3-month disability
OR (95% CI) p value (RC) O R (95% CI) p value (RC)
Dysphagia 3.2 (2.4–4.2) <0.001 (1.15) 2.3 (1.8–3.0) <0.001 (0.82)
EDS within 24 h – – 0.78 (0.51–1.2) 0.2 (–0.24)
Age >65 2.6 (1.8–3.8) <0.001 (0.94) 2.3 (1.8–3.0) <0.001 (0.84)
Male sex 1.1 (0.8–1.3) 0.6 (0.05) 0.6 (0.54–0.77) <0.001 (–0.44)
NIHSS score 1.07 (1.04–1.09) <0.001 (0.06) 1.18 (1.15–1.21) <0.001 (0.16)
Altered consciousness 1.8 (1.3–3.4) <0.001 (0.55) 1.3 (0.8–2.1) 0.2 (0.26)
Speech dysfunction 1.0 (0.7–1.4) 0.9 (0.01) 1.2 (1.0–1.5) 0.058 (0.21)
Hypertension 1.9 (1.2–2.9) 0.004 (0.62) 1.3 (1.0–1.8) 0.04 (0.29)
Diabetes mellitus – – 1.8 (1.5–2.3) <0.001 (0.6)
Previous stroke 1.2 (1.0–1.5) 0.06 (0.21) 1.6 (1.3–2.0) <0.001 (0.47)
Atrial fibrillation 2.0 (1.6–2.5) <0.001 (0.69) 1.5 (1.2–1.8) <0.001 (0.38)























   
   
   
   
   
   
   


























incidence reports from studies that included only pa-
tients with brainstem’s stroke and used video fluoroscop-
ic swallowing examinations  [5, 13–17] . Similar studies 
that included hemispheric strokes and used mostly clini-
cal dysphagia assessments reported lower dysphagia fre-
quencies  [11] . However, in the literature, the incidence 
of dysphagia after stroke varies greatly, ranging from 25 
to 78%, and seems to correlate with the stroke’s severity 
and the type of dysphagia screens techniques  [11, 14, 18, 
19] . The comparatively low rates of dysphagia as well as 
stroke-related pneumonia as revealed in this study may 
be attributed to the design of the study, which included 
patients with AIS. This is due to the exclusion of patients 
with hemorrhagic strokes that are generally associated 
with more severe neurological deficits, particularly al-
tered consciousness and speech dysfunction. In addition, 
only 74.1% of patients underwent systematic dysphagia 
screening. Two main patient groups did not undergo sys-
tematic dysphagia screening. One group consisted of pa-
tients who showed an immediate improvement in neuro-
logical deficits. Patients who did not undergo a dysphagia 
screening were younger and less affected on the NIHSS 
score and had lower rates of neurological symptoms at 
admission. They presented with lower frequencies of vas-
cular risk factors than patients who were screened for 
dysphagia. In addition to this, patients with minor stroke 
might be more frequent in this group. In recent years, a 
gradual change from a time-based definition of transient 
ischemic attack to a tissue-based one  [9, 20–22] has taken 
place. Hence, more patients with transient neurological 
symptoms who showed acute infarction by brain imaging 
were classified as having ischemic stroke according to the 
proposed definition of transient ischemic attack and 
stroke  [9, 22, 23] . However, this could reflect a selection 
bias because MRI was not performed among all patients 
admitted with transient neurological symptoms. Another 
group of patients who are not screened systematically for 
dysphagia might be patients with highly impaired con-
sciousness. For those 2 groups of patients, an apparent 
dysphagia clinical assessment was used instead to deter-
mine the frequency of dysphagia.
 However, the rate of dysphagia screening in our pop-
ulation is higher than that reported in other investiga-
tions reporting that only 50% of stroke patients are being 
screened for dysphagia  [24] . The occurrence of dyspha-
gia in our study was associated with speech dysfunction 
and the conscious disturbance of patients. Thus, taken 
together, patients with dysphagia and altered conscious-
ness may be suffered from more severe stroke than those 
without dysphagia. According to previous studies  [3, 5, 
6, 19, 25, 26] , we found that patients with dysphagia had 
a higher risk of suffering from pneumonia after a stroke. 
This may be explained by the aspiration combined with 
the effect of immunological alteration and other comor-
bidities; on the other hand EDS seems to be correlated 
with a low rate of pneumonia. In this study, we found that 
EDS within 24 h of admission reduced the risk of pneu-
monia noticeably. This could be due to the interventions 
used after dysphagia detection; namely nasogastric tube 
feeding among preselected patients with dysphagia and 
early initiation swallowing therapy to improve cough re-
flex. Other prophylactic procedures such as the estab-
lished methods Nil per or status on admission till dys-
phagia have been excluded, was found to decrease aspira-
tion by targeting swallowing difficulties. These benefits 
of EDS and early interventions after detection of dyspha-
gia in stroke patients have been shown in previous inves-
tigations  [27–29] . While this finding is in accordance 
with the hypothesis that EDS prevents aspiration, we also 
found that the proportion of dysphagia was higher when 
dysphagia screening was performed later. On the other 
hand we have found a strong association between the 
consciousness status and the time point of dysphagia 
screening. Thus, the reasons for performing a later dys-
phagia screening might be that the altered patient’s con-
sciousness at admission did not allow for systematic 
screening, let alone oral food administration. In addition, 
dysphagia was found to be associated with longer hospi-
talization and with increased case fatality and disability 
at discharge; comparable to previous investigations  [30–
33] . On the contrary, we found that the administration of 
EDS was independently correlated with decreased risk of 
disability at discharge from acute care hospitals. A cor-
relation between dysphagia and poorer long-term out-
comes after stroke has been reported in a previous re-
search  [34] . In this study, the rates of mortality and dis-
ability were higher in patients with dysphagia at 3 months 
after discharge. However, an association between EDS 
within 24 h and mortality at 3 months was not found in 
the logistic regression.
 This study had several limitations. As mentioned pre-
viously, only 74% of patients underwent systematic dys-
phagia screening. In addition, approximately one third of 
our investigation was not included in the 3-month fol-
low-up evaluation. Lastly, the dysphagia screening was 
performed clinically using water test and clinical exami-
nation that are less sensitive than the elaborate video flu-
oroscopic swallowing examinations.
 Despite these limitations, our study has several 
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study protocol, and standardized stroke care in accor-
dance with the guidelines of the German Stroke Society. 
Furthermore, the size of the cohort makes this study the 
largest ever-reported dysphagia study investigating dys-
phagia and its assessment in patients with ischemic stroke.
 Summary 
 Our study showed that 25.1% of patients with AIS have 
stroke-related dysphagia. The occurrence of dysphagia 
was strongly associated with longer hospital stay and in-
creased risk of pneumonia and case fatality during hospi-
talization and disability at discharge as well as with high-
er rates of mortality and disability at 3 months after dis-
charge. The administration of EDS appears to improve 
early outcome after stroke.
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